Yes. CD14+ monocytes are widely used to generate macrophages for co-culture. The key is timing: allow differentiation to stabilize phenotype before introducing partners, and keep media compatibility in mind (serum, cytokines, and antibiotics can all shift macrophage behavior). Include macrophage-only controls on every plate to decouple partner-driven effects from baseline drift.
For critical studies, run a quick flow check on a small aliquot post-thaw (CD14 plus a viability dye). If you're differentiating, consider verifying macrophage markers at day 5-7 (e.g., CD68/CD11b) alongside functional readouts like phagocytosis. This provides a two-step confirmation: starting identity and endpoint phenotype.
They can be, as long as you invest in up-front standardization. High-throughput success depends on consistent differentiation timing, uniform seeding, and plate layout controls (edge effects are real). With a 5 × 10^7 vial, you can create enough macrophages for meaningful HTS-scale pilot panels while keeping donor origin constant within the screen.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.